Enter inventor name

Mi Young Lee

USPTO Granted Patents = 25 (Patent Applications = 27)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 86(Granted Patents)

Location History:

Taejon, KR (2001)
Daejon, KR (2002)
Daejeon-Shi, KR (2010)
Deajeon, KR (2017)
Daejeon, KR (2008 - 2022)
Seoul, KR (2017 - 2024)

Company Filing History:

15 out of 11,303

Electronics and Telecommunications Research Institute

patents

5 out of 47

Korea Institute of Oriental Medicine

patents

2 out of 4

Innisfree Corporation

patents

4. 2 out of 624

Korea Research Institute of Chemical Technology

patents

5. 1 out of 1,244

Sungkyunkwan University

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195469 - Compounds having PDE9A inhibitory activity, and pharmaceutical uses thereof (2025-01-14),

2. 12187729 - Compounds having PDE9A inhibitory activity, and pharmaceutical uses thereof (2025-01-07),

3. 11903957 - Composition for preventing, ameliorating, or treating sleep disturbance comprising flavonoid compound as effective component (2024-02-20),

4. 11541088 - Composition for preventing, ameliorating or treating sleep disorders comprising medicinal herb extract as effective ingredient (2023-01-03),

5. 11507799 - Information processing apparatus and method of operating neural network computing device therein (2022-11-22),

6. 11494630 - Neuromorphic arithmetic device and operating method thereof (2022-11-08),

7. 11488003 - Artificial neural network apparatus and operating method for the same (2022-11-01),

8. 11484834 - Method for reducing nitrogen dioxide in exhaust gas generated during olefin production process (2022-11-01),

9. 11455539 - Quantization method and device for weights of batch normalization layer (2022-09-27),

10. 11449720 - Image recognition device, operating method of image recognition device, and computing device including image recognition device (2022-09-20),

11. 11253566 - Composition for ameliorating, or treating depression and anxiety disorder comprisingextract as effective ingredient (2022-02-22),

12. 11204876 - Method and apparatus for controlling memory using prefetch information (2021-12-21),

13. 11003985 - Convolutional neural network system and operation method thereof (2021-05-11),

14. 10061858 - Method and apparatus for processing exploding data stream (2018-08-28),

15. 9990277 - System and method for efficient address translation of flash memory device (2018-06-05),

Title: Mi Young Lee: Innovations in PDE9A Inhibitory Compounds

Introduction

Mi Young Lee, a prolific inventor based in Daejeon, South Korea, holds an impressive portfolio of 25 patents. His work primarily focuses on pharmaceutical compounds with significant therapeutic potential, particularly those related to PDE9A inhibitory activity. Through his pioneering inventions, he has made substantial contributions to medical science.

Latest Patents

One of Mi Young Lee's most notable recent patents pertains to "Compounds having PDE9A inhibitory activity, and pharmaceutical uses thereof." This invention presents a compound with a specific chemical structure that exhibits PDE9A inhibitory activity. Additionally, it describes acceptable pharmaceutical salts and compositions containing these compounds. This invention aims to provide effective treatment or prevention for PDE9A-related diseases by administering the compounds or their salts to patients in need of care.

Career Highlights

Mi Young Lee has made his mark in the scientific community through his tenure at renowned institutions. He has worked at the Electronics and Telecommunications Research Institute and the Korea Institute of Oriental Medicine, where he leveraged his expertise in the development of pharmaceutical innovations. His extensive background in these organizations has enabled him to create impactful inventions that address various health challenges.

Collaborations

Throughout his career, Mi Young Lee has collaborated with talented professionals in the field, including Joo Hyun Lee and Jin Kyu Kim. These collaborations have contributed to the advancement of knowledge and the successful development of innovative solutions in the pharmaceutical industry.

Conclusion

Mi Young Lee exemplifies the spirit of innovation in the realm of pharmaceuticals. With 25 patents to his name and a commendable track record at significant research institutions, he continues to play a vital role in advancing treatments for PDE9A-related diseases. His work reflects a commitment to improving health outcomes through cutting-edge research and collaboration.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com